DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vivelle-DOT (Estradiol) - Drug Ineffective - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Drug Ineffective (24)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vivelle-DOT (Estradiol) where reactions include drug ineffective. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Vivelle-DOT side effects in female

Reported by a physician from United States on 2012-07-25

Patient: female, weighing 160.0 kg (352.0 pounds)

Reactions: Hot Flush, Mood Altered, Sleep Disorder, Drug Ineffective

Drug(s) suspected as cause:
Vivelle-DOT



Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-12

Patient: female

Reactions: Weight Decreased, Night Sweats, Back Pain, Wrong Technique in Drug Usage Process, Drug Ineffective, Nausea, Cystocele, Hot Flush, Fatigue, Insomnia, Enterocele, Multiple Sclerosis, Menopausal Symptoms

Drug(s) suspected as cause:
Vivelle-DOT



Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-02

Patient: female

Reactions: Weight Decreased, Night Sweats, Back Pain, Wrong Technique in Drug Usage Process, Drug Ineffective, Nausea, Cystocele, Hot Flush, Fatigue, Insomnia, Enterocele, Multiple Sclerosis, Menopausal Symptoms

Drug(s) suspected as cause:
Vivelle-DOT



Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-02

Patient: female, weighing 160.0 kg (352.0 pounds)

Reactions: Hot Flush, Sleep Disorder, Drug Ineffective, Mood Altered

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Vivelle-DOT



Possible Vivelle-DOT side effects in

Reported by a pharmacist from United States on 2012-06-15

Patient:

Reactions: Hot Flush, Drug Ineffective, Mood Altered, Sleep Disorder

Drug(s) suspected as cause:
Vivelle-DOT



Possible Vivelle-DOT side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-26

Patient: 48 year old female

Reactions: Wrong Technique in Drug Usage Process, Application Site Scar, Drug Ineffective, Incorrect Dose Administered, Expired Drug Administered, Application Site Pain, Syncope, Fatigue, Dizziness, Depression, Feeling Abnormal, Menopausal Symptoms

Drug(s) suspected as cause:
Vivelle-DOT
    Dosage: 0.1mg, transdermal

Vivelle-DOT
    Dosage: 0.1 mg, twice per week, transdermal

Other drugs received by patient: Diovan HCT; Prevacid; Thyroid TAB; Singulair



Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-26

Patient: female

Reactions: Hot Flush, Drug Ineffective, Insomnia, Depression

Drug(s) suspected as cause:
Vivelle-DOT



Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2012-02-22

Patient: female

Reactions: Wrong Technique in Drug Usage Process, Drug Ineffective, Diverticulitis, Hyperhidrosis, Abdominal Pain Upper, Loss of Consciousness, Frequent Bowel Movements, Malaise, Vomiting, Nausea, Retching, Muscular Weakness, General Physical Health Deterioration, Cognitive Disorder, Cerebrovascular Accident, Tremor, Burning Sensation, Heart Rate Decreased, Diarrhoea, Blood Pressure Fluctuation

Drug(s) suspected as cause:
Estraderm
    Dosage: 0.05 mg, unk

Estraderm
    Dosage: 0.025 mg, unk

Progesterone

Vivelle-DOT
    Dosage: 0.05 mg, qw2
    Start date: 2012-01-08

Other drugs received by patient: Coumadin; Hydroxyurea



Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2012-02-17

Patient: female

Reactions: Fatigue, Drug Ineffective, Arthralgia, Asthenia, Feeling Abnormal, Dysthymic Disorder

Drug(s) suspected as cause:
Vivelle-DOT
    Dosage: 0.05 mg, qw2

Vivelle-DOT
    Dosage: 0.375 mg, unk

Vivelle-DOT
    Dosage: 0.05 mg, qw2

Other drugs received by patient: Prometrium



Possible Vivelle-DOT side effects in female

Reported by a individual with unspecified qualification from United States on 2012-02-08

Patient: female

Reactions: Wrong Technique in Drug Usage Process, Drug Ineffective, Diverticulitis, Hyperhidrosis, Loss of Consciousness, Abdominal Pain Upper, Malaise, Frequent Bowel Movements, Vomiting, Nausea, Retching, Muscular Weakness, Cognitive Disorder, Cerebrovascular Accident, Tremor, Burning Sensation, Heart Rate Decreased, Diarrhoea, Blood Pressure Fluctuation

Drug(s) suspected as cause:
Estraderm
    Dosage: 0.05 mg, unk

Estraderm
    Dosage: 0.025 mg, unk

Progesterone

Vivelle-DOT
    Dosage: 0.05 mg, qw2
    Start date: 2012-01-08

Other drugs received by patient: Coumadin; Hydroxyurea



Possible Vivelle-DOT side effects in female

Reported by a physician from United States on 2012-01-31

Patient: female

Reactions: Fatigue, Drug Ineffective, Arthralgia, Dysthymic Disorder, Asthenia, Feeling Abnormal

Drug(s) suspected as cause:
Vivelle-DOT
    Dosage: 0.375 mg, unk

Vivelle-DOT
    Dosage: 0.05 mg, qw2

Vivelle-DOT
    Dosage: 0.05 mg, qw2

Other drugs received by patient: Progesterone



Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2012-01-25

Patient: female

Reactions: Wrong Technique in Drug Usage Process, Drug Ineffective, Diverticulitis, Hyperhidrosis, Loss of Consciousness, Abdominal Pain Upper, Malaise, Frequent Bowel Movements, Vomiting, Nausea, Retching, Muscular Weakness, Cognitive Disorder, Cerebrovascular Accident, Tremor, Burning Sensation, Heart Rate Decreased, Diarrhoea, Blood Pressure Fluctuation

Drug(s) suspected as cause:
Estraderm
    Dosage: 0.025 mg, unk

Estraderm
    Dosage: 0.05 mg, unk

Progesterone

Vivelle-DOT
    Dosage: 0.05 mg, qw2
    Start date: 2012-01-08

Other drugs received by patient: Hydroxyurea; Coumadin



Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2012-01-19

Patient: female

Reactions: Bladder Prolapse, Drug Ineffective, Pain in Extremity, Fungal Infection, Nervousness

Drug(s) suspected as cause:
Vivelle-DOT
    Dosage: 0.075 mg, twice weekly
    Start date: 2008-01-01

Vivelle-DOT
    Dosage: 0.05 mg
    Indication: Artificial Menopause
    Start date: 2008-03-01
    End date: 2008-01-01



Possible Vivelle-DOT side effects in female

Reported by a physician from United States on 2012-01-12

Patient: female

Reactions: Drug Ineffective, Asthenia, Feeling Abnormal, Dysthymic Disorder

Drug(s) suspected as cause:
Vivelle-DOT

Other drugs received by patient: Prometrium



Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2012-01-12

Patient: female, weighing 136.0 kg (299.2 pounds)

Reactions: Irritability, Anxiety, Product Quality Issue, Night Sweats, Hot Flush, Wrong Technique in Drug Usage Process, Drug Ineffective, Homicidal Ideation, Feeling Abnormal, Menopausal Symptoms

Drug(s) suspected as cause:
Vivelle-DOT
    Indication: Hormone Replacement Therapy
    Start date: 2000-01-01
    End date: 2001-06-01

Vivelle-DOT
    Dosage: 0.075 mg, qw2

Other drugs received by patient: Calcium; Vitamin D



Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2012-01-09

Patient: female, weighing 49.9 kg (109.8 pounds)

Reactions: Vein Disorder, Fibrocystic Breast Disease, Drug Ineffective, Therapeutic Response Unexpected, Breast Mass

Drug(s) suspected as cause:
Estraderm
    Indication: Vulvovaginal Dryness

Medroxyprogesterone Acetate

Vivelle-DOT
    Dosage: 0.037 mg, qw2

Other drugs received by patient: Provera; Calcium Acetate; Vitamins with Minerals



Possible Vivelle-DOT side effects in female

Reported by a individual with unspecified qualification from United States on 2011-12-14

Patient: female

Reactions: Hypersensitivity, Drug Ineffective, Urticaria, Sleep Talking, Pyrexia, Erythema, Application Site Pruritus, Abdominal Discomfort, Malaise, Pharyngeal Oedema, Oedema Peripheral, Cold Sweat, Muscle Spasms, Pain in Extremity, Application Site Pain, Application Site Rash, Middle Insomnia, Insomnia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Antibiotics

Flagyl

Metoprolol Succinate
    Dosage: 50 mg, qd

Ranitidine Hydrochloride
    Dosage: 150 mg, qd
    Administration route: Oral
    Indication: Gastrooesophageal Reflux Disease

Vivelle-DOT
    Dosage: 0.05 mg, qw2
    Start date: 1995-01-01

Vivelle-DOT
    Dosage: 0.05 mg, qw2

Other drugs received by patient: Ascorbic Acid; Vitamin E; Vitamin B NOS; Naproxen Sodium; Vitamin D; Zinc; Similasan; Toprol-XL; Vitamin A; Potassium Chloride; Tylenol-500; Equate (Acetylsalicylic Acid); Zantac



Possible Vivelle-DOT side effects in female

Reported by a physician from United States on 2011-12-02

Patient: female

Reactions: Drug Ineffective, Dysthymic Disorder, Feeling Abnormal, Asthenia

Drug(s) suspected as cause:
Vivelle-DOT

Other drugs received by patient: Prometrium



Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2011-11-28

Patient: female, weighing 49.9 kg (109.8 pounds)

Reactions: Vein Disorder, Fibrocystic Breast Disease, Drug Ineffective, Therapeutic Response Unexpected, Breast Mass

Drug(s) suspected as cause:
Estraderm
    Dosage: 0.05
    Indication: Vulvovaginal Dryness

Medroxyprogesterone Acetate

Vivelle-DOT
    Dosage: 0.037 mg, qw2

Other drugs received by patient: Provera; Calcium; Vitamins with Minerals



Possible Vivelle-DOT side effects in female

Reported by a individual with unspecified qualification from United States on 2011-11-28

Patient: female

Reactions: Hypersensitivity, Drug Ineffective, Urticaria, Sleep Talking, Pyrexia, Erythema, Application Site Pruritus, Abdominal Discomfort, Pharyngeal Oedema, Malaise, Oedema Peripheral, Cold Sweat, Muscle Spasms, Pain in Extremity, Application Site Rash, Insomnia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Antibiotics

Flagyl

Metoprolol Succinate
    Dosage: 50 mg, qd

Ranitidine Hydrochloride
    Dosage: 150 mg, qd
    Administration route: Oral
    Indication: Gastrooesophageal Reflux Disease

Vivelle-DOT
    Dosage: 0.05 mg, qw2
    Start date: 1995-01-01

Vivelle-DOT
    Dosage: 0.05 mg, qw2

Other drugs received by patient: Similasan; Zinc; Vitamin A; Naproxen Sodium; Equate (Acetylsalicylic Acid); Zantac; Ascorbic Acid; Vitamin E; Potassium Acetate; Toprol-XL; Vitamin D; Vitamin B NOS; Tylenol-500



Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2011-11-22

Patient: female

Reactions: Drug Ineffective, Asthenia, Feeling Abnormal, Dysthymic Disorder

Drug(s) suspected as cause:
Vivelle-DOT

Other drugs received by patient: Prometrium



Possible Vivelle-DOT side effects in female

Reported by a individual with unspecified qualification from United States on 2011-11-21

Patient: female

Reactions: Vein Disorder, Fibrocystic Breast Disease, Drug Ineffective, Breast Mass

Drug(s) suspected as cause:
Medroxyprogesterone Acetate

Vivelle-DOT
    Dosage: 0.037 mg, qw2

Other drugs received by patient: Provera



Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2011-10-24

Patient: female, weighing 136.0 kg (299.2 pounds)

Reactions: Irritability, Anxiety, Night Sweats, Hot Flush, Wrong Technique in Drug Usage Process, Drug Ineffective, Feeling Abnormal, Menopausal Symptoms

Drug(s) suspected as cause:
Vivelle-DOT
    Indication: Hormone Replacement Therapy
    Start date: 2000-01-01
    End date: 2001-06-01

Vivelle-DOT
    Dosage: 0.075 mg, qw2

Other drugs received by patient: Vitamin D; Calcium Carbonate



Possible Vivelle-DOT side effects in female

Reported by a individual with unspecified qualification from United States on 2011-10-04

Patient: female, weighing 56.7 kg (124.7 pounds)

Reactions: Product Quality Issue, Night Sweats, Drug Ineffective, Irritability, Anxiety, Hot Flush, Blood Oestrogen Decreased, Feeling Abnormal, Crying, Menopausal Symptoms

Drug(s) suspected as cause:
Vivelle-DOT

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017